US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist

20.210
-1.220-5.69%

Close May 13 16:00 ET

20.210
0.0000.00%

Post 16:00 ET

1.82BMarket Cap-7485P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-71.36%-54.6M

-1,424.13%-141.22M

-36.45M

-31.86M

136.14%10.67M

-301.92%-29.51M

-7.34M

Net income from continuing operations

-123.16%-93.77M

-681.73%-176.94M

---39.6M

---42.02M

45.83%-22.63M

-490.94%-41.79M

---7.07M

Operating gains losses

1,231.02%41.37M

-51.56%5.23M

--400.01K

--3.11M

1,410.81%10.79M

-2,688.05%-823K

---29.52K

Depreciation and amortization

66.67%15K

444.44%49K

--27.95K

--9K

80.00%9K

306.52%5K

--1.23K

Other non cash items

-50.00%1K

-99.93%6K

---5.63M

--2K

8.61%8.01M

1,717.51%7.38M

--405.88K

Change In working capital

-1,647.76%-10.14M

-43.45%5.87M

--2.8M

---580K

132.06%10.37M

788.31%4.47M

---649.41K

-Change in prepaid assets

167.66%956K

196.32%4.03M

--5.47M

---1.41M

20.01%-4.19M

-213.47%-5.23M

---1.67M

-Change in payables and accrued expense

-337.72%-9.69M

372.35%10.54M

---933.05K

--4.08M

-139.89%-3.87M

851.52%9.7M

--1.02M

-Change in other working capital

56.81%-1.4M

-147.24%-8.71M

---1.74M

---3.24M

--18.43M

----

Cash from discontinued investing activities

Operating cash flow

-71.36%-54.6M

-1,424.13%-141.22M

---36.45M

---31.86M

136.14%10.67M

-301.92%-29.51M

---7.34M

Investing cash flow

Cash flow from continuing investing activities

-5,400.00%-385K

89.14%-24K

5.63M

-7K

-820.83%-221K

-50.10%-24K

-15.99K

Net PPE purchase and sale

-5,400.00%-385K

89.14%-24K

--2.65K

---7K

-820.83%-221K

-50.10%-24K

---15.99K

Cash from discontinued investing activities

Investing cash flow

-5,400.00%-385K

89.14%-24K

--5.63M

---7K

-820.83%-221K

-50.10%-24K

---15.99K

Financing cash flow

Cash flow from continuing financing activities

8,185.12%198.18M

-97.73%8.91M

6.33M

2.39M

362.68%391.91M

508.37%84.7M

13.92M

Net issuance payments of debt

----

--0

----

--747K

--0

--13.92M

Net common stock issuance

--190.48M

--0

--8.75M

--0

368.63%396.95M

--84.7M

--0

Proceeds from stock option exercised by employees

284.74%9.2M

--8.91M

----

--2.39M

--0

----

Net other financing activities

---1.5M

----

---5.79M

----

Cash from discontinued financing activities

Financing cash flow

8,185.12%198.18M

-97.73%8.91M

--6.33M

--2.39M

362.68%391.91M

508.37%84.7M

--13.92M

Net cash flow

Beginning cash position

-27.21%340.45M

677.85%467.73M

--441.31M

--467.73M

523.38%60.13M

213.70%9.65M

--3.07M

Current changes in cash

585.76%143.19M

-132.89%-132.33M

---24.5M

---29.48M

629.32%402.35M

740.43%55.17M

--6.56M

Effect of exchange rate changes

-181.52%-2.5M

-3.73%5.05M

---8.89M

--3.06M

212.06%5.25M

-15,964.44%-4.68M

--29.52K

End cash Position

9.03%481.15M

-27.21%340.45M

--416.76M

--441.31M

677.85%467.73M

521.92%60.13M

--9.67M

Free cash flow

-72.54%-54.99M

-1,452.37%-141.24M

---36.45M

---31.87M

135.36%10.44M

-301.37%-29.54M

---7.36M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-71.36%-54.6M	-1,424.13%-141.22M	-36.45M	-31.86M	136.14%10.67M	-301.92%-29.51M	-7.34M
Net income from continuing operations	-123.16%-93.77M	-681.73%-176.94M	---39.6M	---42.02M	45.83%-22.63M	-490.94%-41.79M	---7.07M
Operating gains losses	1,231.02%41.37M	-51.56%5.23M	--400.01K	--3.11M	1,410.81%10.79M	-2,688.05%-823K	---29.52K
Depreciation and amortization	66.67%15K	444.44%49K	--27.95K	--9K	80.00%9K	306.52%5K	--1.23K
Other non cash items	-50.00%1K	-99.93%6K	---5.63M	--2K	8.61%8.01M	1,717.51%7.38M	--405.88K
Change In working capital	-1,647.76%-10.14M	-43.45%5.87M	--2.8M	---580K	132.06%10.37M	788.31%4.47M	---649.41K
-Change in prepaid assets	167.66%956K	196.32%4.03M	--5.47M	---1.41M	20.01%-4.19M	-213.47%-5.23M	---1.67M
-Change in payables and accrued expense	-337.72%-9.69M	372.35%10.54M	---933.05K	--4.08M	-139.89%-3.87M	851.52%9.7M	--1.02M
-Change in other working capital	56.81%-1.4M	-147.24%-8.71M	---1.74M	---3.24M	--18.43M	----	----
Cash from discontinued investing activities
Operating cash flow	-71.36%-54.6M	-1,424.13%-141.22M	---36.45M	---31.86M	136.14%10.67M	-301.92%-29.51M	---7.34M
Investing cash flow
Cash flow from continuing investing activities	-5,400.00%-385K	89.14%-24K	5.63M	-7K	-820.83%-221K	-50.10%-24K	-15.99K
Net PPE purchase and sale	-5,400.00%-385K	89.14%-24K	--2.65K	---7K	-820.83%-221K	-50.10%-24K	---15.99K
Cash from discontinued investing activities
Investing cash flow	-5,400.00%-385K	89.14%-24K	--5.63M	---7K	-820.83%-221K	-50.10%-24K	---15.99K
Financing cash flow
Cash flow from continuing financing activities	8,185.12%198.18M	-97.73%8.91M	6.33M	2.39M	362.68%391.91M	508.37%84.7M	13.92M
Net issuance payments of debt	----	--0	----	----	--747K	--0	--13.92M
Net common stock issuance	--190.48M	--0	--8.75M	--0	368.63%396.95M	--84.7M	--0
Proceeds from stock option exercised by employees	284.74%9.2M	--8.91M	----	--2.39M	--0	--0	----
Net other financing activities	---1.5M	----	----	----	---5.79M	----	----
Cash from discontinued financing activities
Financing cash flow	8,185.12%198.18M	-97.73%8.91M	--6.33M	--2.39M	362.68%391.91M	508.37%84.7M	--13.92M
Net cash flow
Beginning cash position	-27.21%340.45M	677.85%467.73M	--441.31M	--467.73M	523.38%60.13M	213.70%9.65M	--3.07M
Current changes in cash	585.76%143.19M	-132.89%-132.33M	---24.5M	---29.48M	629.32%402.35M	740.43%55.17M	--6.56M
Effect of exchange rate changes	-181.52%-2.5M	-3.73%5.05M	---8.89M	--3.06M	212.06%5.25M	-15,964.44%-4.68M	--29.52K
End cash Position	9.03%481.15M	-27.21%340.45M	--416.76M	--441.31M	677.85%467.73M	521.92%60.13M	--9.67M
Free cash flow	-72.54%-54.99M	-1,452.37%-141.24M	---36.45M	---31.87M	135.36%10.44M	-301.37%-29.54M	---7.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall